Volatile organic compound detection of Buruli ulcer disease: Headspace analysis of Mycobacterium ulcerans and used gauzes of Buruli-compatible ulcers.

Autor: Chudy SFJ; Department of Respiratory Medicine, Academic Medical Centre, Amsterdam, The Netherlands., Phanzu DM; Institut Medical Evangélique de Kimpese (IME), Kimpese, Democratic Republic of Congo.; Centre de Recherche en Santé de Kimpese (CRSK), Kimpese, Democratic Republic of Congo., Kolk AHJ; Department of Respiratory Medicine, Academic Medical Centre, Amsterdam, The Netherlands., Sopoh GE; Centre De Dépistage et de Traitement de l'Ulcère de Buruli (CDTUB), Allada, Benin., Barogui YT; World Health Organisation (WHO), Brazzaville, Congo., Tzfadia O; Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium., Eddyani M; Independent consultant, Antwerp, Belgium., Fissette K; Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium., de Jong BC; Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium., Brinkman P; Department of Respiratory Medicine, Academic Medical Centre, Amsterdam, The Netherlands.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Sep 23; Vol. 18 (9), pp. e0012514. Date of Electronic Publication: 2024 Sep 23 (Print Publication: 2024).

Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda

Autor: Ngabonziza, J.-C.S., Habimana, Y.M., Decroo, T., Migambi, P., Dushime, A., Mazarati, J.B., Rigouts, L., Affolabi, D., Ivan, E., Meehan, Conor J., Van Deun, A., Fissette, K., Habiyambere, I., Nyaruhirira, A.U., Turate, I., Semahore, J.M., Ndjeka, N., Muvunyi, C.M., Condo, J.U., Gasana, M., Hasker, E., Torrea, G., de Jong, B.C.

Yes
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin dr

Externí odkaz: http://hdl.handle.net/10454/17785

Significant under expression of the DosR regulon in M. tuberculosis complex lineage 6 in sputum

Autor: Ofori-Anyinam, B., Dolganov, G., Van, T., Davis, J.L., Walter, N.D., Garcia, B.J., Voskuil, M., Fissette, K., Diels, M., Driesen, M., Meehan, Conor J., Yeboah-Manu, D., Coscolla, M., Gagneux, S., Antonio, M., Schoolnik, G., Gehre, F., de Jong, B.C.

Yes
Mycobacterium africanum lineage (L) 6 is an important pathogen in West Africa, causing up to 40% of pulmonary tuberculosis (TB). The biology underlying the clinical differences between M. africanum and M. tuberculosis sensu stricto remains p

Externí odkaz: http://hdl.handle.net/10454/17574

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis.

Autor: Rigouts L; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium. lrigouts@itg.be., Keysers J; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium., Rabab R; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium., Fissette K; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium., van Deun A; Independent Consultant, Louvain, Belgium., de Jong BC; Institute of Tropical Medicine, Mycobacteriology Unit, Nationalestraat 155, Antwerp, Belgium.

Publikováno v: BMC research notes [BMC Res Notes] 2023 Jul 14; Vol. 16 (1), pp. 146. Date of Electronic Publication: 2023 Jul 14.

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region.

Autor: Ngabonziza JCS; National Reference Laboratory Division, Department of Biomedical Services, Rwanda Biomedical Center, Kigali, Rwanda.; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Biomedical Sciences, Antwerp University, Antwerp, Belgium., Loiseau C; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Marceau M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017, CIIL - Center for Infection and Immunity of Lille, 59000, Lille, France., Jouet A; Genoscreen, Lille, France., Menardo F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Tzfadia O; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Antoine R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017, CIIL - Center for Infection and Immunity of Lille, 59000, Lille, France., Niyigena EB; National Reference Laboratory Division, Department of Biomedical Services, Rwanda Biomedical Center, Kigali, Rwanda., Mulders W; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Fissette K; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Diels M; BCCM/ITM, Mycobacterial Culture Collection, Institute of Tropical Medicine, Antwerp, Belgium., Gaudin C; Genoscreen, Lille, France., Duthoy S; Genoscreen, Lille, France., Ssengooba W; Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda., André E; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium., Kaswa MK; National Tuberculosis Program, Kinshasa, DR, Congo., Habimana YM; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Center, Kigali, Rwanda., Brites D; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Affolabi D; Laboratoire de Référence des Mycobactéries, Cotonou, Benin., Mazarati JB; Department of Biomedical Services, Rwanda Biomedical Center, Kigali, Rwanda., de Jong BC; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Rigouts L; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Biomedical Sciences, Antwerp University, Antwerp, Belgium., Gagneux S; Swiss Tropical and Public Health Institute, Basel, Switzerland. sebastien.gagneux@swisstph.ch.; University of Basel, Basel, Switzerland. sebastien.gagneux@swisstph.ch., Meehan CJ; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. c.meehan2@bradford.ac.uk.; School of Chemistry and Biosciences, University of Bradford, Bradford, UK. c.meehan2@bradford.ac.uk., Supply P; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017, CIIL - Center for Infection and Immunity of Lille, 59000, Lille, France. philip.supply@ibl.cnrs.fr.

Publikováno v: Nature communications [Nat Commun] 2020 Jun 09; Vol. 11 (1), pp. 2917. Date of Electronic Publication: 2020 Jun 09.